Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
W. Bradford Middlekauff currently holds 8,213 shares of Edge Therapeutics, Inc. (EDGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, W. Bradford Middlekauff has been a net seller of EDGE stock. They have purchased $94.8K and sold $1.6M worth of shares.
W. Bradford Middlekauff's most recent insider trade was on Oct 28, 2025, when they sold 8,213 shares at $0.00 per share.
W. Bradford Middlekauff serves as Executive at Edge Therapeutics, Inc. (EDGE). They have executed 18 insider transactions totaling $1.7M over their tenure at the company.
W. Bradford Middlekauff holds the position of Executive at Edge Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
W. Bradford Middlekauff has shown a selling trading pattern, with $94.8K in total purchases and $1.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by W. Bradford Middlekauff was on Mar 17, 2006, when they sold $1.4M worth of MEDX shares. This transaction involved 100,000 shares at $13.88 per share.
W. Bradford Middlekauff currently owns 8,213 shares of Edge Therapeutics, Inc. (EDGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of W. Bradford Middlekauff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. W. Bradford Middlekauff has 18 Form 4 filings on record as an insider at Edge Therapeutics, Inc..
Set alerts for W. Bradford Middlekauff and 40,000+ other insiders.